What is the global market size of Bone Growth Stimulators Market?

Global Bone Growth Stimulators Market size was valued at USD 1.84 billion in 2021 and is poised to grow from USD 1.93 billion in 2022 to USD 2.70 billion by 2030, at a CAGR of 4.9% during the forecast period (2023-2030).

Who are the key vendors in the Global Bone Growth Stimulators Market?

The competitive landscape for the bone growth stimulator industry contains information on each competitor. A business overview, financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, product launches, product breadth and depth, and application dominance are all included in the data. 'Zimmer Biomet Holdings, Inc. (United States)', 'Stryker Corporation (United States)', 'Medtronic plc (Ireland)', 'Orthofix Medical Inc. (United States)', 'DJO Global, Inc. (United States)', 'Bioventus LLC (United States)', 'DePuy Synthes (a Johnson & Johnson Company) (United States)', 'Arthrex, Inc. (United States)', 'Smith & Nephew plc (United Kingdom)', 'Elizur Corporation (United States)', 'Isto Biologics (United States)', 'Ossatec Benelux B.V. (Netherlands)', 'Terumo Corporation (Japan)', 'RTI Surgical Holdings, Inc. (United States)', 'Bioventus LLC (United States)', 'Ember Therapeutics (United States)', 'Isto Biologics (United States)', 'DePuy Synthes Spine (United States)', 'Aetna Inc. (United States)', 'Ossatec Benelux B.V. (Netherlands)', 'BONESUPPORT AB (Sweden)', 'Regen Lab SA (Switzerland)'

Bone Growth Stimulators Market Size, Share, Growth Analysis, By Product(Bone Growth Stimulation Devices {External Bone Growth Stimulators (Pulsed electromagnetic field devices, Combined magnetic field devices, Capacitive coupling devices), Ultrasonic Bone Growth Stimulators), By Application(Spinal Fusion Surgeries, Delayed Union & Non-Union Bone Fractures, Oral & Maxillofacial Surgeries, Others), By End User(Hospitals & Ambulatory Surgical Centers, Home Care Settings, Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2314 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 63 | Figures: 77

Bone Growth Stimulators Market News

In January 2024, Orthofix Medical Inc. received FDA clearance for its next-generation bone growth stimulator, the AccelStim. This device is designed to provide non-invasive treatment for nonunion fractures, leveraging low-intensity pulsed ultrasound (LIPUS) to promote bone growth and healing.
In May 2023, Zimmer Biomet announced the availability of the Zimmer Biomet Amplitude, a new bone growth stimulator. For the treatment of nonunion and delayed union fractures, The Amplitude is an external, non-invasive bone growth stimulator.
In April 2023, Osteotech, a business that creates and produces bone growth stimulators, was acquired by Medtronic. With the acquisition, Medtronic will be able to increase the number of bone growth stimulators in its lineup and break into the growing spinal fusion surgery market.
In March 2023, Smith & Nephew announced the release of the Smith & Nephew OsteoStim, a novel bone growth stimulator. A non-invasive external bone growth stimulator called the OsteoStim is used to treat fractures with delayed union and nonunion.

Bone Growth Stimulators Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).

The competitive landscape for the bone growth stimulator industry contains information on each competitor. A business overview, financials, revenue generated, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, product launches, product breadth and depth, and application dominance are all included in the data. 'Zimmer Biomet Holdings, Inc. (US) ', 'Stryker Corporation (US) ', 'Medtronic plc (Ireland) ', 'Orthofix Medical Inc. (US) ', 'Bioventus LLC (US) ', 'Arthrex, Inc. (US) ', 'Smith & Nephew plc (UK) ', 'Elizur Corporation (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'Terumo Corporation (Japan) ', 'Bioventus LLC (US) ', 'Ember Therapeutics (US) ', 'Isto Biologics (US) ', 'Ossatec Benelux B.V. (Netherlands) ', 'BONESUPPORT AB (Sweden) ', 'Regen Lab SA (Switzerland) ', 'Cerapedics, Inc. (US) ', 'Orthocell Ltd. (Australia) ', 'Alphatec Spine, Inc. (US) ', 'Bone Therapeutics SA (Belgium) ', 'EndoStim, Inc. (US)'

The rising prevalence of orthopedic conditions, such as fractures, delayed unions, non-unions, and osteoporosis-related fractures, is a significant driver for the bone growth stimulators market. As the aging population grows and the incidence of orthopedic conditions rises, the demand for bone growth stimulators increases.

In the present, the bone growth stimulators industry is being influenced by various consequential developments. A standout tendency is the increase in demand for treatments that are more amiable to patients and less invasive. In order to promote bone mending, bone growth stimulators are becoming a more popular choice for both healthcare providers and patients due to their ability to serve as a less intrusive alternative to conventional surgical means. This inclination is particularly noticeable when treating orthopedic ailments like spinal fusion, fractures, and others.

In 2022, North America had a predominant share of USD 0.72 billion. For bone growth stimulators, North America is the largest market. The market is expanding in North America due to the increased incidence of orthopedic injuries and disorders, the aging population, and the rising demand for less invasive procedures. The main elements promoting regional domination are the rising costs of healthcare, the prevalence of related bone illnesses, and the occurrences of these conditions that call for the administration of bone growth stimulators. The high shares of this region will also be strongly impacted by the robust procedure volumes related to orthopedic disorders.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Bone Growth Stimulators Market News

Bone Growth Stimulators Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Bone Growth Stimulators Market?

Who are the key vendors in the Bone Growth Stimulators Market?

What is the key driver of Bone Growth Stimulators Market?

What is the key market trend for Bone Growth Stimulators Market?

Which region accounted for the largest share in Bone Growth Stimulators Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300